Gyre Therapeutics Q4 Adj. EPS $0.05 Misses $0.06 Estimate, Sales $37.195M Beat $36.303M Estimate

Gyre Therapeutics (NASDAQ:GYRE) reported quarterly earnings of $0.05 per share which missed the analyst consensus estimate of $0.06 by 26.98 percent. This is a 253.85 percent increase over earnings of $0.01 per share from the same period last year. The company reported quarterly sales of $37.195 million which beat the analyst consensus estimate of $36.303 million by 2.46 percent. This is a 33.45 percent increase over sales of $27.872 million the same period last year.